ADENOMAS HIPOFISARIOS DE BAJA PREVALENCIA: UN ARTÍCULO DE REVISIÓN

Autores/as

  • Sara Henao Romero Pontificia Universidad Javeriana
  • Daniel Villamizar-Torres Estudiante Pontificia Universidad Javeriana
  • Oscar Feo lee Neurocirujano

Palabras clave:

Neoplasias hipofisarias, Adenohipófisis, Hormonas Adenohipofisarias, Diagnóstico.

Resumen

RESUMEN

 Introducción: Los adenomas hipofisarios constituyen un diverso grupo de neoplasias intracraneales, los cuales destacan por sus amplias manifestaciones clínicas relacionadas a los síndromes endocrinológicos secundarios y el compromiso neurológico, resaltando como una de las neoplasias más interesantes en el ámbito de la neurocirugía. Existe abundante literatura respecto a los grupos más frecuentes de adenomas hipofisarios, sin embargo sus integrantes menos comunes tienden a quedar en el olvido, razón por lo cual se realizó una revisión de la literatura con el objetivo de recopilar la información disponible, unificando la fisiopatología, diagnóstico y manejo dentro de un artículo que provea al lector las herramientas necesarias para el correcto abordaje de los grupos de adenomas menos frecuentes.

 

Materiales y métodos: Se realizó una búsqueda en las principales bases de datos científicas con términos MeSH durante diciembre 2020- Julio 2021.

 

Conclusiones:

A pesar de constituir patologías de baja frecuencia estas pueden generar un compromiso severo en la calidad de vida de los pacientes, que en gran parte podría ser prevenido con un diagnóstico temprano de las alteraciones endocrinológicas y su compromiso neurológico y una rápida remisión a servicios especializados. Sin embargo constituyen un reto diagnóstico, secundario a la amplia desinformación con respecto a estos grupos tumorales y sus manifestaciones clínicas, las cuales pueden asemejarse muchas veces a patologías de alta frecuencia dentro de la población general.

Biografía del autor/a

Sara Henao Romero, Pontificia Universidad Javeriana

Residente de Neurocirugía, Pontificia Universidad Javeriana Bogotá D.C., Colombia. sarahenaor@gmail.com

Daniel Villamizar-Torres, Estudiante Pontificia Universidad Javeriana

 Semillero de Neurología y Neurocirugía, Pontificia Universidad Javeriana Bogotá D.C., Colombia.  Villamizar.daniel2102@gmail.com

Citas

AlMalki, M.H., Ahmad, M.M., Brema, I., AlDahmani, K.M., Pervez, N., Al-Dandan,

S. et al l. 2020. Contemporary Management of Clinically Non-functioning

Pituitary Adenomas: A Clinical Review. Clinical Medicine Insights: Endocrinology

and Diabetes Jun;13:117955142093292-1179551420932921. https://doi.org/

1177/1179551420932921

Arafah, B.M. 1986. Reversible hypopituitarism in patients with large

nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62: 1173–1179.

https://doi.org/ 10.1210/jcem-62-6-1173

Black PM, Hsu DW, Klibanski A, Kliman B, Jameson JL, Ridgway EC, Hedley-White

ET, Zervas NT. 1987. Hormone production in clinically nonfunctioning pituitary

adenomas. J Neurosurg 66: 244–250. https://doi.org/

3171/jns.1987.66.2.0244

Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R.C., Weintraub, B.D.

Thyrotropin-secreting pituitary tumors. Endocr Rev.;17:610–38.

https://doi.org/ 10.1210/edrv-17-6-610

Beck-Peccoz, P., Persani, L., Mannavola, D., Campi, I. 2009. Pituitary tumours:

TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab;23:597–606.

https://doi.org/ 10.1016/j.beem.2009.05.006.

Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., Wemeau, J.2013 . 2013

European Thyroid Association Guidelines for the Diagnosis and Treatment ofNeurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 82

Thyrotropin-Secreting Pituitary Tumors. European thyroid journal Jun;2(2):76-

https://doi.org/ 10.1159/000351007

Biller, B.M., Findling, J.W., Murad, M.H., Newell-Pricem J,. Savage, M.O. et al. 1987.

Treatment of adrenocorticotropindependent Cushing’s syndrome: a consensus

statement. J Clin Endocrinol Metab 93:2454–2462, 2008. https://doi.org/

1210/jc.2007-2734

Chaudhary, V., Bano, S. 2011. Imaging of the pituitary: Recent advances. Indian

journal of endocrinology and metabolism Sep;15 Suppl 3(7):S216-S223.

https://doi.org/10.4103/2230-8210.84871

Cury, M. Fernandes, J.C., Machado, H.R., Elias, L.L., Moreira, A.C., Castro. M. 2009.

Non-functioning pituitary adenomas: clinical feature, laboratorial and imaging

assessment, therapeutic management and outcome. Arquivos brasileiros de

endocrinologia e metabologia Feb;53(1):31-39. https://doi.org/ 10.1590/s0004-

Daly, A.F,. Burlacu, M.C., Livadariu E.,Et al .2007. The Epidemiology and

Management of Pituitary Incidentalomas. Hormone research in paediatrics,

(5), pp. 195-198. . https://doi.org/ 10.1159/000110624

Dworakowska, D., Grossman, A. B. 2009. The pathophysiology of pituitary

adenomas. Best Practice & Research: Clinical Endocrinology & Metabolism

;23(5):525-541. https://doi.org/10.1016/j.beem.2009.05.004

Ebersold, M.J., Quast, L.M., Laws, E.R., Scheithauer, B., Randall, R.V. 1986. Longterm results in transsphenoidal removal of nonfunctioning pituitary adenomas.

J Neurosurg.;64:713-9. https://doi.org/ 10.3171/jns.1986.64.5.0713

Elster, A. D.1993. Imaging of the sella: Anatomy and pathology. Semin

Ultrasound CT MR. 1993;14:182–94. https://doi.org/10.1016/s0887-

(05)80079-4

Evanson, J. 2019. Radiology of the Pituitary. Encyclopedia of Endocrine Diseases,

Second Edition. Second Edition ed.: Elsevier Inc. p. 339-348.Neurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 83

Fukuhara, N., Horiguchi, K., Nishioka, H. et al. 2015. Short-term preoperative

octreotide treatment for TSH-secreting pituitary adenoma. Endocr J 62:21–27.

https://doi.org/ 10.1507/endocrj.EJ14-0118

Gao,R., Isoda, H., Tanaka, T., Inagawa, S., Takeda, H., Takehara, Y., et al. 2001.

Dynamic gadolinium enhanced MR imaging of pituitary adenomas: Usefulness

of sequential sagittal and coronal plane images. Eur J Radiol.;39:139–46.

https://doi.org/ 10.1016/s0720-048x(01)00354-0

Gilsanz, A., Moreno, B., Obiols, G., Zugasti, A., Català, M., Lucas, T. et al. 2006.

Guía clínica del diagnóstico y tratamiento de los tumores hipofisarios no

funcionantes y gonadotropinomas. Endocrinologia y nutricion;53(1):13-18.

https://doi.org/ 10.1016/S1575-0922(06)71060-9

Gittleman, H., Ostrom, Q.T., Farah. P.D., et al. 2014. Descriptive epidemiology of

pituitary tumors in the United States, 2004–2009. Journal of neurosurgery,

(3), pp. 527-535. . https://doi.org/ 10.3171/2014.5.JNS131819

Gurnell, M., Visser, T.J., Beck-Peccoz, P., Chatterjee, V.K.K. 2010. Resistance to

thyroid hormone; in Jameson LJ, DeGroot LJ (eds): Endocrinology, Adult and

Pediatric, ed 6. Philadelphia, Saunders Elsevier., vol II, pp 1745–1759

Halperin,R. Camara, R., Garcia, M., Ollero, D. 2012. Clinical guidelines for

diagnosis and treatment of prolactinoma and hyperprolactinemia.

Endocrinologia y nutrición (English ed.);60(6):308-319.

https://doi.org/10.1016/j.endonu.2012.11.005

Harris, P.E. 1988 Biochemical markers for clinically non-functioning pituitary

tumours. Clin Endocrinol;49:163-4. https://doi.org/ 10.1046/j.1365-

1998.00539.x

Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T. Lopes, MB, et al. 2021. Pituitary

Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Journal of the Endocrine Society Mar 1,;5(3). . https://doi.org/

1210/jendso/bvaa205Neurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 84

Iglesias, P., Arcano, K., Triviño, V. et al. 2017. Prevalence, clinical features, and

natural history of incidental clinically non-functioning pituitary adenomas. Horm

Metab Res.;49:654-659. https://doi.org/ 10.1055/s-0043-115645

Jagannathan, J., Smith, R., DeVroom, H.L., Vortmeyer, A.O., Stratakis, C.A.,

Nieman, L.K. et al. 2009. Outcome of using the histological pseudocapsule as a

surgical capsule in Cushing disease. J Neurosurg 111:531–539.

https://doi.org/10.3171/2008.8.JNS08339

Katznelson, L., Laws, E.R., Melmed, S., Molitch, M.E., Murad, M.H., Utz, A.,et al.

Acromegaly: An Endocrine Society Clinical Practice Guideline. The journal

of clinical endocrinology and metabolism Nov;99(11):3933-3951.

https://doi.org/10.1210/jc.2014-2700

Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., Gurnell, M. 2013. Pitfalls in the

measurement and interpretation of thyroid function tests. Best Pract Res Clin

Endocrinol Metab 27:745–762. https://doi.org/10.1016/j.beem.2013.10.003

Kovacs, K., Scheithauer, B.W., Horvath, E., Lloyd, R.V. et al. 1996. The World

Health Organization classification of adenohypophysial neoplasms. A proposed

five-tier scheme. Cancer;78:502-10. https://doi.org/ 10.1002/(SICI)1097-

(19960801)78:3<502::AID-CNCR18>3.0.CO;2-2

Lamberts, S.W.J., Nobels, F.R.2002 Clinically nonfunctioning pituitary tumours

and gonadotrophinomas. En: Wass JA, ShaletSM, editores. Oxford textbook

of endocrinology and diabetes.Oxford: Oxford University Press. p. 192-8.

Lonser, R.R., Nieman L., Oldfield, E.H. 2017. Cushing's disease: pathobiology,

diagnosis, and management. Journal of neurosurgery Feb;126(2):404-417

https://doi.org/ 10.3171/2016.1.JNS152119

Lopes, M.B.S. 2017. The 2017 World Health Organization classification of tumors

of the pituitary gland: a summary. Acta Neuropathol Oct;134(4):521-535.

https://doi.org/10.1007/s00401-017-1769-8

Losa, M., Giovanelli, M., Persani, L., Faglia, G., Beck-Peccoz, P. 1996. Criteria of

cure and follow-up of central hyperthyroidism due to thyrotropin-secreting

pituitary adenomas. J Clin Endocrinol Metab 81:3086–3090. https://doi.org/

1210/jcem.81.8.8768879Neurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 85

Losa, M., Mortini, P., Barzaghi, R., Franzin, A., Giovanelli, M. 2001. Endocrine

inactive and gonadotroph adenomas: diagnosis and management. J Neurooncol

Sep;54(2):167-177. https://doi.org/ 10.1023/a:1012965617685

Melmed S., Casanueva, F.F., Hoffman, A.R., Kleinberg, D.L., Montori, V.M.,

Schlechte, J.A. et al. 2011. Diagnosis and Treatment of Hyperprolactinemia: An

Endocrine Society Clinical Practice Guideline. The journal of clinical

endocrinology and metabolism Feb;96(2):273-288 https://doi.org/

1210/jc.2010-1692

Melmed, S. 2020. Pituitary-Tumor Endocrinopathies. The New England journal

of medicine Mar 5,;382(10):937-950. https://doi.org/10.1056/NEJMra1810772

Newell-Price, J.,Trainer, P., Besser, M., Grossman, A. 1998. The diagnosis and

differential diagnosis of Cushing’s syndrome and pseudoCushing’s states.

Endocr Rev; 19: 647–72. https://doi.org/ 10.1210/edrv.19.5.0346

Newell-Price J. , Bertagna, X., Grossman, A.B., Nieman, L.K. 2006. Cushing's

syndrome. The Lancet (British edition);367(9522):1605-1617.

https://doi.org/10.1016/S0140-6736(14)61375-1.

Nieman, L.K., Biller, B.M.K., Findling, J.W., Newell-Price, J., Savage, M.O., Stewart,

P.M., et al. 2008. The Diagnosis of Cushing's Syndrome: An Endocrine Society

Clinical Practice Guideline. The journal of clinical endocrinology and metabolism

May;93(5):1526-1540. https://doi.org/ 10.1210/jc.2008-0125

Nieman, L.K., Biller, B.M.K., Findling, J.W., Murad, M.H., Newell-Price, J., Savage,

M.O. et al. 2015. Treatment of Cushing's Syndrome: An Endocrine Society Clinical

Practice Guideline. The journal of clinical endocrinology and metabolism

Aug;100(8):2807-2831. https://doi.org/10.1210/jc.2015-1818

Nieman, L.K. 2018 .Recent Updates on the Diagnosis and Management of

Cushing's Syndrome. Endocrinology and metabolism (Seoul) Jun;33(2):139-146.

https://doi.org/ 10.3803/EnM.2018.33.2.139

Oldfield, E.H., Doppman, J.L., Nieman, L.K. et al.1991. Petrosal sinus sampling

with and without corticotropin-releasing hormone for the differential diagnosisNeurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 86

of Cushing’s syndrome. N Engl J Med; 325: 897–905. https://doi.org/

1056/NEJM199109263251301

Onnestam, L., Berinder, K., Burman, P., Dahlqvist, P., Engstrom, B.E., Wahlberg,

J., Nystrom, H.F. 2013. National incidence and prevalence of TSH-secreting

pituitary adenomas in Sweden. Journal of Clinical Endocrinology and

Metabolism. 98 626–635. https://doi.org/ 10.1210/jc.2012-3362

O’Sullivan, E.P., Woods, C., Glynn, N., et al. 2009. The natural history of surgically

treated but radiotherapy-naive nonfunctioning pituitary adenomas. Clin

Endocrinol;71:709-714. https://doi.org/ 10.1111/j.1365-2265.2009.03583.x.

Persani, L., Preziati, D., Matthews, C.H., Sartorio, A., Chatterjee, V.K., Beck-Peccoz,

P. 1997. Serum levels of carboxyterminal crosslinked telopeptide of type I

collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate

secretion of TSH. Clinical Endocrinology 47 207–214. https://doi.org/

1046/j.1365- 2265.1997.2351057.x

Pickett, CA. 2003. Diagnosis and management of pituitary tumors: recent

advances. Primary care ;30(4):765-789. https://doi.org/10.1016/s0095-

(03)00094-0.

Raffi, ML., De Keyzer, Y,. Bertagna, X. 2003. Proopiomelanocortin, a polypeptide

precursor with multiple functions: from physiology to pathological conditions.

Eur J Endocrinol; 149: 79–90. https://doi.org/ 10.1530/eje.0.1490079

Reimondo, G,. Paccott,i P., Minetto, M. et al. 2003. The corticotrophinreleasing

hormone test is the most reliable noninvasive method to differentiate pituitary

from ectopic ACTH secretion in Cushing’s syndrome. Clin Endocrinol (Oxf); 58:

–24. https://doi.org/10.1046/j.1365-2265.2003.01776.x

Ross, E.J., Linch, D.C .1982. Cushing’s syndrome— killing disease: discriminatory

value of signs and symptoms aiding early diagnosis. Lancet 2:646 – 649.

https://doi.org/ 10.1016/s0140-6736(82)92749-0

Sheehan, J., Lee, C.C., Bodach, M.E., et al. 2016. Congress of neurological

surgeon’s systematic review and evidence-based guideline for the managementNeurociencias Journal Vol 28 Núm 3 Henao S y Cols.

Página | 87

of patients with residual or recurrent nonfunctioning pituitary adenomas.

Neurosurgery;79:E539-E540. https://doi.org/ 10.1227/NEU.0000000000001385

Socin, H.V., Chanson, P., Delemer, B., Tabarin, A., Rohmer, V., Mockel, J.,

Stevenaert, A., Beckers, A. 2003. The changing spectrum of TSHsecreting

pituitary adenomas: diagnosis and management in 43 patients. European

Journal of Endocrinology 148 433–442. https://doi.org/ 10.1530/eje.0.1480433

Tjörnstrand, A., Nyström, H.F. 2017. Diagnostic approach to TSH-producing

pituitary adenoma. European journal of endocrinology ;177(4):R183.

https://doi.org/ 10.1530/EJE-16-1029

Yamada, S., Fukuhara, N., Horiguchi, K., Yamaguchi-Okada, M., Nishioka, H.,

Takeshita, A., Takeuchi, Y., Ito, J., Inoshita, N. 2014. Clinicopathological

characteristics and therapeutic outcomes in thyrotropin-secreting pituitary

adenomas: a single-center study of 90 cases. Journal of Neurosurgery 121 1462–

https://doi.org/ 10.3171/2014.7.JNS1471

Descargas

Publicado

2022-03-29

Cómo citar

Henao Romero, S., Villamizar-Torres, D., & Feo lee, O. (2022). ADENOMAS HIPOFISARIOS DE BAJA PREVALENCIA: UN ARTÍCULO DE REVISIÓN . Neurociencias Journal, 28(3), 69–87. Recuperado a partir de https://www.neurocienciasjournal.com/index.php/neurocienciasjournal/article/view/276

Número

Sección

Artículo de revisión